Medulloblastoma—Biology and Microenvironment: A Review

REFERENCES

• Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer. Jan 2010;10(1):59–64.
   PubMed Web of Science ®Google Scholar
• Ryan SL, Schwalbe EC, Cole M, MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol. 2012;123:501–513.
   PubMed Web of Science ®Google Scholar
• Korshunov A, Remk M, Kool M, Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. Acta Neuropathol. 2012;123:515–527.
   PubMed Web of Science ®Google Scholar
• Lindberg E, Persson A, Ora I, et al. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma. Neuropathology. Dec 2007;27(6):556–560.
   PubMed Web of Science ®Google Scholar
• Whitfield JR, Soucek L. Tumor microenvironment: becoming sick of Myc. Cell Mol Life Sci. Oct 28 2012;69:931–934.
   PubMed Web of Science ®Google Scholar
• Breit S, Ashman K, Wilting J, The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res. Aug 15 2000; 60(16):4596–4601.
   PubMed Web of Science ®Google Scholar
• Noujaim D, van Golen CM, van Golen KL, et al. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene. Jul 4 2002;21(29):4549–4557.
   PubMed Web of Science ®Google Scholar
• Oikawa M, Yoshiura K, Kondo H, et al. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization. Radiat Oncol. 2011;6:168.
   PubMed Web of Science ®Google Scholar
• Castellino RC, De Bortoli M, Lu X, Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol. Feb 2008;86(3):245–256.
   PubMed Web of Science ®Google Scholar
• Fuller C, Fouladi M, Gajjar A, et al. Chromosome 17 abnormalities in pediatric neuroblastic tumor with abundant neuropil and true rosettes. Am J Clin Pathol. Aug 2006;126(2):277–283.
   PubMed Web of Science ®Google Scholar
• Biegel JA, Burk CD, Barr FG, Emanuel BS. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. Jun 15 1992;52(12):3391–3395.
   PubMed Web of Science ®Google Scholar
• Pan E, Pellarin M, Holmes E, Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res. Jul 1 2005;11(13):4733–4740.
   PubMed Web of Science ®Google Scholar
• Nam DH, Wang KC, Kim YM, et al. The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma. J Korean Med Sci. Aug 2000;15(4):452–456.
   PubMed Web of Science ®Google Scholar
• Loda M, Giangaspero F, Badiali M, et al. p53 gene expression in medulloblastoma by quantitative polymerase chain reaction. Diagn Mol Pathol. Mar 1992;1(1):36–44.
   PubMedGoogle Scholar
• Gilbertson RJ. Medulloblastoma: signalling a change in treatment. Lancet Oncol. Apr 2004;5(4):209–218.
   PubMed Web of Science ®Google Scholar
• Rous P. A Transmissible avian neoplasm. (Sarcoma of the common fowl.). J Exp Med. Sep 1 1910;12(5):696–705.
   PubMedGoogle Scholar
• Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med. Apr 1 1911;13(4):397–411.
   PubMedGoogle Scholar
• Murphy JB, Rous P. The behavior of Chicken Sarcoma implanted in the developing embryo. J Exp Med. Feb 1 1912;15(2):119–132.
   PubMedGoogle Scholar
• Rubin H, Temin HM. Infection with the Rous sarcoma virus in vitro. Fed Proc. Dec 1958;17(4):994–1003.
   PubMedGoogle Scholar
• Temin HM, Rubin H. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology. Dec 1958;6(3):669–688.
   PubMed Web of Science ®Google Scholar
• Tarpley WG, Temin HM. The location of v-src in a retrovirus vector determines whether the virus is toxic or transforming. Mol Cell Biol. Dec 1984;4(12):2653–2660.
   PubMed Web of Science ®Google Scholar
• Garcia De Viedma D, Diaz Infantes M, Miralles P, JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions. Clin Infect Dis. Jun 15, 2002;34(12):1568–1575.
   PubMed Web of Science ®Google Scholar
• Caracciolo V, Reiss K, Khalili K, Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene. Aug 28 2006;25(38):5294–5301.
   PubMed Web of Science ®Google Scholar
• Felsani A, Mileo AM, Paggi MG. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene. Aug 28 2006;25(38):5277–5285.
   PubMed Web of Science ®Google Scholar
• Bollag B, Prins C, Snyder EL, Frisque RJ. Purified JC virus T and T’ proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology. Aug 15 2000;274(1):165–178.
   PubMed Web of Science ®Google Scholar
• Howard CM, Claudio PP, De Luca A, Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. Cancer Res. May 15 2000;60(10):2737–2744.
   PubMed Web of Science ®Google Scholar
• White MK, Khalili K. Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene. Aug 28 2006;25(38):5286–5293.
   PubMed Web of Science ®Google Scholar
• Caracciolo V, Reiss K, Crozier-Fitzgerald C, Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg. J Cell Physiol. Jul 2007;212(1):96–104.
   PubMed Web of Science ®Google Scholar
• Del Valle L, Baehring J, Lorenzana C, et al. Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas. Mol Pathol. Oct 2001;54(5):331–337.
   PubMedGoogle Scholar
• Takakura K, Inoya H, Nagashima K, et al. Viral neurooncogenesis. Prog Exp Tumor Res. 1987;30:10–20.
   PubMed Web of Science ®Google Scholar
• Caracciolo V, Macaluso M, D'Agostino L, Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma. J Cell Biochem. May 2010;110(1):182–190.
   PubMed Web of Science ®Google Scholar
• Zu Rhein GM. Studies of JC virus-induced nervous system tumors in the Syrian hamster: a review. Prog Clin Biol Res. 1983;105:205–221.
   PubMedGoogle Scholar
• Padgett BL, Walker DL, ZuRhein GM, Varakis JN. Differential neurooncogenicity of strains of JC virus, a human polyoma virus, in newborn Syrian hamsters. Cancer Res. Mar 1977;37(3):718–720.
   PubMed Web of Science ®Google Scholar
• Krynska B, Otte J, Franks R, et al. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene. Jan 7 1999;18(1):39–46.
   PubMed Web of Science ®Google Scholar
• Munoz-Marmol AM, Mola G, Ruiz-Larroya T, Rarity of JC virus DNA sequences and early proteins in human gliomas and medulloblastomas: the controversial role of JC virus in human neurooncogenesis. Neuropathol Appl Neurobiol. Apr 2006;32(2):131–140.
   PubMed Web of Science ®Google Scholar
• Vasishta RK, Pasricha N, Nath A, Sehgal S. The absence of JC virus antigens in Indian children with medulloblastomas. Indian J Pathol Microbiol. Jan–Mar 2009;52(1):42–45.
   PubMed Web of Science ®Google Scholar
• Krynska B, Del Valle L, Croul S, Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A. Sep 28 1999;96(20):11519–11524.
   PubMed Web of Science ®Google Scholar
• Weggen S, Bayer TA, von Deimling A, Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. Jan 2000;10(1):85–92.
   PubMed Web of Science ®Google Scholar
• Pereira L, Maidji E, Fisher SJ, et al. HCMV persistence in the population: potential transplacental transmission. In: Arvin A, Campadelli-Fiume G, Mocarski E, , eds. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press, 2007.
   Google Scholar
• Shimamura M, Murphy-Ullrich JE, Britt WJ. Human cytomegalovirus induces TGF-beta1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition. PLoS Pathog. 2010;6(11):e1001170. doi:10.1371/journal.ppat.1001170.
   Web of Science ®Google Scholar
• Cobbs CS, Soroceanu L, Denham S, Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness. J Neurooncol. Dec 2007;85(3):271–280.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Huang L, Anders DG. Human cytomegalovirus oriLyt sequence requirements. J Virol. Jun 1998;72(6):4989–4996.
   PubMed Web of Science ®Google Scholar
• Straat K, Liu C, Rahbar A, Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst. Apr 1 2009;101(7):488–497.
   PubMedGoogle Scholar
• Baryawno N, Rahbar A, Wolmer-Solberg N, Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest. Oct 2011;121(10):4043– 4055.
   PubMed Web of Science ®Google Scholar
• Karbowniczek M, Cash T, Cheung M, et al. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. J Biol Chem. Jul 16 2004;279(29):29930–29937.
   PubMed Web of Science ®Google Scholar
• Koch A, Hrychyk A, Hartmann W, Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int J Cancer. Jul 15 2007;121(2):284–291.
   PubMed Web of Science ®Google Scholar
• Rubenfeld M, Abramson DH, Ellsworth RM, Kitchin FD. Unilateral vs. bilateral retinoblastoma. Correlations between age at diagnosis and stage of ocular disease. Ophthalmology. Aug 1986;93(8):1016–1019.
   PubMed Web of Science ®Google Scholar
• Rausch T, Jones DT, Zapatka M, Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations. Cell. Jan 20 2012;148(1-2):59–71.
   PubMed Web of Science ®Google Scholar
• Pfaff E, Remke M, Sturm D, TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol. Dec 10 2010;28(35):5188–5196.
   PubMed Web of Science ®Google Scholar
• Rieber J, Remke M, Hartmann C, Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. Genes Chromosomes Cancer. Jul 2009;48(7):558–568.
   PubMed Web of Science ®Google Scholar
• Eichenmuller M, Bauer R, Von Schweinitz D, et al. Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice. Int J Oncol. Aug 2007;31(2):405–412.
   PubMed Web of Science ®Google Scholar
• Rice JM. Inducible and transmissible genetic events and pediatric tumors of the nervous system. J Radiat Res (Tokyo). 2006;47 Suppl B:B1–11.
   PubMedGoogle Scholar
• Cowan R, Hoban P, Kelsey A, et al. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer. 1997;76(2):141–145.
   PubMed Web of Science ®Google Scholar
• Calzada-Wack J, Kappler R, Schnitzbauer U, Unbalanced overexpression of the mutant allele in murine Patched mutants. Carcinogenesis. May 2002;23(5):727–733.
   PubMed Web of Science ®Google Scholar
• Wetmore C, Eberhart DE, Curran T. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res. Apr 15 2000;60(8):2239–2246.
   PubMed Web of Science ®Google Scholar
• Zurawel RH, Allen C, Wechsler-Reya R, et al. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer. May 2000;28(1):77–81.
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Liu B, Parsons RE, The molecular basis of Turcot's syndrome. N Engl J Med. Mar 30 1995;332(13):839–847.
   PubMed Web of Science ®Google Scholar
• Lindsey JC, Lusher ME, Anderton JA, Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis. May 2004;25(5):661–668.
   PubMed Web of Science ®Google Scholar
• Crawford JR, MacDonald TJ, Packer RJ. Medulloblastoma in childhood: new biological advances. Lancet Neurol. Dec 2007;6(12):1073–1085.
   PubMed Web of Science ®Google Scholar
• Gajjar A, Hernan R, Kocak M, Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. Mar 15 2004;22(6):984–993.
   PubMed Web of Science ®Google Scholar
• Gilbertson RJ. ERBB2 in pediatric cancer: innocent until proven guilty. Oncologist. Aug 2005;10(7):508–517.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Ratnayake M, Savoldo B, Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. Jun 15 2007;67(12):5957–5964.
   PubMed Web of Science ®Google Scholar
• Gulino A, Arcella A, Giangaspero F. Pathological and molecular heterogeneity of medulloblastoma. Curr Opin Oncol. Nov 2008;20(6):668–675.
   PubMed Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. Aug 1989;8(2):98–101.
   PubMed Web of Science ®Google Scholar
• Fokas E, Engenhart-Cabillic R, Daniilidis K, et al. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev. Dec 2007;26(3-4):705–715.
   PubMed Web of Science ®Google Scholar
• Weber CE, Kuo PC. The tumor microenvironment. Surg Oncol. Sep 29 2011.
   Web of Science ®Google Scholar
• Witz IP. The tumor microenvironment: the making of a paradigm. Cancer Microenviron. Sep 2009;2 Suppl 1:9–17.
   Google Scholar
• Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. Apr 2009;9(4):239–252.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. Mar 4 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. Apr 2005;4(4):365–370.
   PubMed Web of Science ®Google Scholar
• Salsman VS, Chow KK, Shaffer DR, Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment. PLoS One. 2011;6(5):e20267.
   PubMed Web of Science ®Google Scholar
• Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol. May 2002;282(5):C947–970.
   PubMed Web of Science ®Google Scholar
• Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells. 1997;15(3):180–189.
   PubMed Web of Science ®Google Scholar
• Xian X, Hakansson J, Stahlberg A, Pericytes limit tumor cell metastasis. J Clin Invest. Mar 2006;116(3):642–651.
   PubMed Web of Science ®Google Scholar
• Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. Dec 1992;153(3):557–562.
   PubMed Web of Science ®Google Scholar
• Kimura H, Weisz A, Ogura T, Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem. Jan 19 2001;276(3):2292–2298.
   PubMed Web of Science ®Google Scholar
• Slongo ML, Molena B, Brunati AM, Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro Oncol. Oct 2007;9(4):384–392.
   PubMed Web of Science ®Google Scholar
• Tural S, Gercek A, Konya D, et al. Microvessel density and vascular endothelial growth factor expression as predictors of childrens’ survival from cerebellar medulloblastoma. J Clin Neurosci. Sep 2009;16(9):1199–1202.
   PubMed Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. Jan 2006;6(1):24–37.
   PubMed Web of Science ®Google Scholar
• Deschoolmeester V, Baay M, Van Marck E, Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol. 2010;11:19.
   PubMed Web of Science ®Google Scholar
• Ruffell B, Au A, Rugo HS, et al. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. Aug 8 2012;109:2796–2801.
   PubMed Web of Science ®Google Scholar
• Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol. Nov 1 2010;185(9):4977–4982.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Martin A, Gomez L, Lustgarten J, et al. Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells. Cancer Res. Aug 15 2011;71(16):5455–5466.
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev. Feb 2008;18(1):11–18.
   PubMed Web of Science ®Google Scholar
• Wakabayashi O, Yamazaki K, Oizumi S, CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci. Nov 2003;94(11):1003–1009.
   PubMed Web of Science ®Google Scholar
• Vincent S, Mirshari M, Nicolas C, Large-cell medulloblastoma with arrestin-like protein expression. Clin Neuropathol. Jan-Feb 2003;22(1):1–9.
   PubMed Web of Science ®Google Scholar
• Salama P, Phillips M, Grieu F, Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. Jan 10 2009;27(2):186–192.
   PubMed Web of Science ®Google Scholar
• Zhou P, Sha H, Zhu J. The role of T-helper 17 (Th17) cells in patients with medulloblastoma. J Int Med Res. Mar-Apr 2010;38(2):611–619.
   PubMed Web of Science ®Google Scholar
• Wiegering V, Eyrich M, Rutkowski S, et al. TH1 predominance is associated with improved survival in pediatric medulloblastoma patients. Cancer Immunol Immunother. May 2011;60(5):693–703.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Salsman VS, Kew Y, HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res. Jan 15 2010;16(2):474–485.
   PubMed Web of Science ®Google Scholar